Related Experiment Video
Updated: Jul 23, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
Circ_LRP6 facilitates osteosarcoma progression via the miR-122-5p/miR-204-5p/HMGB1 axis
Guanghui Wang1, Xiyuan Wei2, Shan Gao1
1Department of Orthopedic Surgery, Zhumadian Central Hospital, Zhumadian, Henan, China.
Environmental Toxicology
|July 14, 2023
Summary
Circular RNA LRP6 (circ_LRP6) promotes osteosarcoma progression by regulating the miR-122-5p/miR-204-5p/HMGB1 axis. This study identifies circ_LRP6 as a potential biomarker for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Circular RNA LRP6 (circ_LRP6) is implicated in various cancers.
- The specific role and mechanism of circ_LRP6 in osteosarcoma (OS) remain largely unelucidated.
Purpose of the Study:
- To investigate the function and underlying molecular mechanisms of circ_LRP6 in osteosarcoma development.
- To determine if circ_LRP6 acts as a potential diagnostic biomarker for osteosarcoma.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure expression levels of circ_LRP6, miR-122-5p, miR-204-5p, and HMGB1.
- Cell counting kit-8 (CCK-8) and Transwell assays to assess cell proliferation, migration, and invasion.
- Bioinformatics analysis and dual-luciferase reporter assays to confirm molecular interactions.
- In vivo studies using a subcutaneous tumor formation model in nude mice.
Main Results:
- Osteosarcoma tissues exhibited significantly higher expression of circ_LRP6 and HMGB1, and lower expression of miR-122-5p and miR-204-5p compared to normal tissues.
- Knockdown of circ_LRP6 markedly inhibited osteosarcoma cell proliferation, migration, and invasion in vitro and tumor growth in vivo.
- Bioinformatics and experimental validation confirmed circ_LRP6 targets miR-122-5p and miR-204-5p, which in turn target HMGB1.
- Restoration of miR-122-5p/miR-204-5p or HMGB1 partially reversed the effects of circ_LRP6 knockdown.
Conclusions:
- Circ_LRP6 promotes osteosarcoma progression through the miR-122-5p/miR-204-5p/HMGB1 signaling pathway.
- Circ_LRP6 serves as a potential molecular biomarker for osteosarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K

